Westfield Capital Management
CAI

Westfield Capital Management’s Caris Life Sciences CAI Stock Holding History

Westfield Capital Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,000
Closed -$802K – 282
2025
Q2 		$802K Buy
+30,000
New +$809K ﹤0.01% 226

Other funds holding CAI

SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Westfield Capital Management's CAI Position: Q3 2025 in Review

Westfield Capital Management sold out of Caris Life Sciences (CAI) in Q3 2025, closing a stake of 30,000 shares — an estimated $802K sold.

Westfield Capital Management first reported a position in CAI in Q2 2025 and held it in 1 quarter. The position peaked at $802K in Q2 2025. 138 funds tracked by Wall St. Rank hold CAI as of Q3 2025.

  • Westfield Capital Management reported no remaining Caris Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Westfield Capital Management sold 30,000 Caris Life Sciences shares in Q3 2025, an estimated $802K.
  • Westfield Capital Management first reported a position in Caris Life Sciences in Q2 2025 and held it in 1 quarter.
  • Westfield Capital Management's Caris Life Sciences position peaked at $802K in Q2 2025.
  • 138 funds tracked by Wall St. Rank held Caris Life Sciences as of Q3 2025.

Based on Westfield Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.